Phosphinegold(I) Thiolates in Medicine
Author Information
Author(s): Edward R.T. Tiekink
Primary Institution: National University of Singapore
Hypothesis
Can new phosphinegold(I) thiolates be developed to improve treatment for rheumatoid arthritis and exhibit anti-tumour activity?
Conclusion
Phosphinegold(I) thiolates show potential for developing more effective treatments for rheumatoid arthritis and anti-tumour agents.
Supporting Evidence
- Gold compounds have been used in medicine for thousands of years.
- Phosphinegold(I) thiolates have shown promising anti-arthritic and anti-tumour activities.
- Certain phosphinegold(I) compounds exhibited higher potency and lower toxicity compared to existing treatments.
Takeaway
Scientists are studying gold compounds to help treat arthritis and cancer better. They found some new gold compounds that work really well and have fewer side effects.
Methodology
The study involved in vivo screening of phosphinegold(I) thiolates in dark Agouti rats for anti-arthritic activity and cytotoxicity testing in various cancer cell lines.
Limitations
The study primarily focuses on in vivo models and may not fully translate to human responses.
Participant Demographics
Dark Agouti rats were used as the animal model for testing.
Want to read the original?
Access the complete publication on the publisher's website